PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck
Titel:
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck
Auteur:
Wirth, Lori J. Dakhil, Shaker Kornek, Gabriela Axelrod, Rita Adkins, Douglas Pant, Shubham O’Brien, Paul Debruyne, Philip R. Oliner, Kelly S. Dong, Jun Murugappan, Swami